Exhaled breath condensate (EBC) carries abundant information on airway health and disease, as well as systemic disease. Current EBC samplers focus on volatile compounds and protein biomarkers. This approach does not allow for analysis of biomolecules (e.g. DNA, proteins, metabolites). We are developing an optimised EBC biomolecule sampler and analyser using EBC microbiomics (infectious disease) as a validation approach.
|Publication status||Published - 22 Nov 2018|
|Event||Molecular Diagnostics World Summit 2018 - Hilton London Olympia Hotel, London, United Kingdom|
Duration: 22 Nov 2018 → 23 Nov 2018
|Conference||Molecular Diagnostics World Summit 2018|
|Abbreviated title||MOLRDIAX 2018|
|Period||22/11/18 → 23/11/18|